Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Melanoma
Interventions
BIOLOGICAL

Ipilimumab

DRUG

Chemotherapy

Trial Locations (17)

18103

Lehigh Valley Hospital, Allentown

24105

Local Institution, Kiel

33075

Local Institution, Bordeaux

35205

Birmingham Hematology & Oncology Associates Llc, Birmingham

37075

Local Institution, Göttingen

44093

Local Institution, Nantes

46260

Investigative Clinical Research Of Indiana, Llc, Indianapolis

50937

Local Institution, Cologne

53100

Local Institution, Siena

67214

Cancer Center Of Kansas, Wichita

69115

Local Institution, Heidelberg

75010

Local Institution, Paris

75246

Texas Oncology Sammons Cancer Center, Dallas

80012

Rocky Mountain Cancer Centers, Aurora

89148

Comprehensive Cancer Center Of Nevada, Las Vegas

99089

Local Institution, Erfurt

A-1090

Local Institution, Vienna

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01709162 - Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma | Biotech Hunter | Biotech Hunter